TWO SIGMA INVESTMENTS, LP - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$2,972,000
-84.1%
20,400
-87.0%
0.01%
-81.8%
Q1 2022$18,659,000
-32.2%
157,363
-21.2%
0.06%
-6.8%
Q4 2021$27,533,000
+19.4%
199,793
+20.3%
0.06%
+13.5%
Q3 2021$23,062,000
+418.0%
166,022
+262.0%
0.05%
+420.0%
Q2 2021$4,452,000
-52.3%
45,857
-66.4%
0.01%
-58.3%
Q1 2021$9,337,000
-44.4%
136,605
-30.3%
0.02%
-50.0%
Q4 2020$16,788,000
-6.4%
195,875
-29.0%
0.05%
-25.0%
Q3 2020$17,934,000
+182.8%
275,865
+218.0%
0.06%
+106.5%
Q2 2020$6,342,000
+119.4%
86,744
+2.1%
0.03%
+29.2%
Q1 2020$2,891,000
-78.7%
84,963
-65.9%
0.02%
-41.5%
Q4 2019$13,582,000
+442.0%
249,479
+315.4%
0.04%
+412.5%
Q3 2019$2,506,000
+264.2%
60,060
+282.5%
0.01%
+300.0%
Q2 2019$688,000
-94.1%
15,700
-93.1%
0.00%
-94.7%
Q1 2019$11,718,000
+3346.5%
227,666
+1571.8%
0.04%
+3700.0%
Q2 2017$340,00013,6180.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders